Please assess the completion status of the following clinical trial:

Trial Title: Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* After the participating physician's decision has been made to initiate once-daily Levemir® therapy, any patient with Type 2 diabetes who is currently treated with diet, exercise and one or more OADs can be offered to participate~Exclusion Criteria:~* Current treatment with insulin~* Known or suspected allergy to Levemir® or excipients~* Children below the age of 6 years~* Females of childbearing potential who are pregnant, breast-feeding or intend to become pregnant within the next 6 months or are not using adequate contraceptive methods (contraceptive measures as required by local law or practice)

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Insulin detemir (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).